tiprankstipranks
Trending News
More News >
Algernon Pharmaceuticals Extends Warrant Expiry Date to November 2025
PremiumCompany AnnouncementsAlgernon Pharmaceuticals Extends Warrant Expiry Date to November 2025
2M ago
Psychedelic: Clearmind initiates U.S. clinical site for CMND-100 trial
Premium
The Fly
Psychedelic: Clearmind initiates U.S. clinical site for CMND-100 trial
3M ago
Algernon Pharmaceuticals receives notice of allowance from EPO for Repirinast
Premium
The Fly
Algernon Pharmaceuticals receives notice of allowance from EPO for Repirinast
3M ago
Psychedelic: Relmada acquires neurosteroid from Asarina
PremiumThe FlyPsychedelic: Relmada acquires neurosteroid from Asarina
5M ago
Algernon Pharmaceuticals appoints Validcare as CRO for Phase 2a DMT trial
Premium
The Fly
Algernon Pharmaceuticals appoints Validcare as CRO for Phase 2a DMT trial
5M ago
Algernon Pharmaceuticals Secures Patent for Lead CKD Drug
Premium
Company Announcements
Algernon Pharmaceuticals Secures Patent for Lead CKD Drug
6M ago
Algernon Pharmaceuticals Launches Private Placement
PremiumCompany AnnouncementsAlgernon Pharmaceuticals Launches Private Placement
11M ago
Algernon Pharmaceuticals Completes Key Funding Round
Premium
Company Announcements
Algernon Pharmaceuticals Completes Key Funding Round
11M ago
Algernon Pharmaceuticals Boosts Private Placement
Premium
Company Announcements
Algernon Pharmaceuticals Boosts Private Placement
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100